Case report systemic mastocytosis in a patient with bcr-abl1-positive chronic myeloid leukemia in the remission phase

HIGHLIGHTS

• who: Christos Fokoloros and colleagues from the National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece have published the article: Case Report Systemic Mastocytosis in a Patient with BCR-ABL1-Positive Chronic Myeloid Leukemia in the Remission Phase, in the Journal: Case Reports in Hematology of 25/Oct/2022
• what: The authors report a case of diagnosing SM in a patient in complete molecular remission of CML after stopping TKI treatment.

SUMMARY

Systemic mastocytosis (SM) is a rare myeloid neoplasm. According to current guidelines, SM is classifed into subgroups . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.